# NeuroServo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuroservo

- Industry: Medical Devices & Equipment
- Headquarters: Montreal, Canada
- Website: www.neuroservo.com
- Total disclosed funding: $1.7M
- Latest round: Seed (Jun 20, 2023)
- Investors on record: 3

## About

Based in Quebec, Canada, and founded in 2015 by CEO Nicolas Tremblay and COO Jérôme Arnaud, NeuroServo Inc., a.k.a. NeuroServo operates as a medical devices and equipment company that designs and develops an electroencephalogram (EEG) to detect possible brain pathology. In June 2023, NeuroServo Inc. raised CAD 2.2 million in seed funding from the Centre for Aging + Brain Health Innovation, Desjardins Capital, and Investissement Québec.

The company provides an electroencephalogram (EEG), a brain wave capture device for ICU (intensive care unit) and ER (emergency room) with continuous monitoring, real-time brainwave analysis, and pathology detection.

NeuroServo plans to use its proceeds from June 2023 funding to accelerate its growth and expand beyond Canada.

## Funding rounds

- Seed, Jun 20, 2023, $1.7M — Investment Quebec, Desjardins Capital, Centre for Aging + Brain Health Innovation

## Investors

- Investment Quebec (https://capitalatlas.ai/funds/investment-quebec) — Seed
- Desjardins Capital (https://capitalatlas.ai/funds/desjardins-capital) — Seed
- Centre for Aging + Brain Health Innovation — Seed